GENEXPLAIN GMBH

GENEXPLAIN GMBH

Grant-FundedCORDIS

Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

Visit website
🇩🇪 Wolfenbuttel, Germany·genexplain.com
AI / ML · Biotech · SaaS
GENEXPLAIN GMBH is a private SME recorded in CORDIS in Germany, with participation in 12 EU research and innovation projects. Its recorded projects include “Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€4,542,010
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇩🇪Germany
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics

Startup insights

Value proposition

GENEXPLAIN GMBH is a private SME recorded in CORDIS in Germany, with participation in 12 EU research and innovation projects. Its recorded projects include “Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.

AI / MLBiotechSaaS
Tags:AI / MLBiotechSaaS

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime